Intravenous Rituximab in Severe Refractory Primary Focal Segmental Glomerulosclerosis

Intravenous Rituximab in Severe Refractory Primary Focal Segmental Glomerulosclerosis

Managing primary or even secondary glomerulonephritis remains a challenge to many nephrologists. In primary focal segmental glomerulosclerosis (FSGS) with heavy proteinuria, renin aldosterone system blockade and high dose of oral prednisolone is the mainstay of treatment. Other immunosuppressive med...

Full description

Bibliographic Details
Main Authors: Wee Leng Gan, Ruslinda Mustafar, Lydia Kamaruzaman, Rozita Mohd, Rizna Abdul Cader, Wei Yen Kong, Kiew Bing Pau
Format: Article
Language:English
Published: Interna Publishing 2018-10-01
Series:Acta Medica Indonesiana
Subjects:
refractory focal segmental glomerulosclerosis
intravenous Rituximab
Online Access:http://actamedindones.org/index.php/ijim/article/view/790

Internet

http://actamedindones.org/index.php/ijim/article/view/790

Similar Items